Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with relapsing-remitting multiple sclerosis (RRMS) based on a specific set of diagnostic standards known as the 2017 revised McDonald criteria
- People who are currently being treated with, or are starting or switching to, a type of MS medication that works by targeting B cells (a type of immune cell), used according to the approved prescribing guidelines
- People whose level of physical disability, as measured by a standard MS scoring tool called the EDSS, falls between 0.0 and 7.0 (this scale measures how MS affects movement and daily function)
Who may not be able to join:
- People who have previously been treated with any of the following medications or procedures: alemtuzumab, cladribine, cyclophosphamide, mitoxantrone, azathioprine, mycophenolate mofetil, cyclosporine, methotrexate, total body irradiation, or bone marrow transplantation
- People who have a medical, psychiatric, cognitive, or other condition that, in the trial doctor's judgement, would affect their ability to understand the study information and give informed consent
- People who are receiving immune-suppressing medication for a condition other than MS, or who are on long-term steroid treatment
- People who have a confirmed diagnosis of HIV (Human Immunodeficiency Virus) or Hepatitis C
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +492118117889
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the peripheral immune cell profile; Change from baseline in protein profile of the peripheral blood; Change from baseline in TCR/BCR profile
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.